{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260326279809/en/Rocket-Pharmaceuticals-Announces-FDA-Approval-of-KRESLADI%E2%84%A2-for-Pediatric-Patients-with-Severe-Leukocyte-Adhesion-Deficiency-I-LAD-I", "message": "News view counter 628711 successfully enlarged"}